FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...

BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and autoimmune therapeutics, today ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and metastatic cancer, today announced that it has submitted ...

Propanc Biopharma (PPCB) submitted a request for a foreign filing license from Spain for two provisional patents detailing new methods to treat ...

Mum-of-five, Katie Price, 47, has warned her followers about the dangers of vaping, telling fans she needs to kick the habit ...

The decade-long expansion could transform lung care and research in Uganda. Thank you for reading Nation.Africa Show plans In a historic step toward addressing the country’s increasing burden of ...

In 1969, Rod Macleod was training to become a child psychiatrist at Montreal Children’s Hospital. It was a busy and exciting ...

The most common chronic progressive fibrosing ILD is IPF.1,2 PPF is another form of progressive fibrotic lung disease that ...

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...

NIPPV is a treatment where a machine is used to help the person breathe. During NIPPV therapy, the person breathes using a mask that forces the air into the lungs, keeping the airways open and ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

Nigeria has been ranked among the countries with the lowest life expectancy in the world, according to the latest data released by the United Nations’ World Population Prospects portal. The report ...